Genmab A/S's total assets for Q2 2025 were kr41.08B, a decrease of -9.68% from the previous quarter. GB:0MGB total liabilities were kr7.39B for the fiscal quarter, a -17.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.